Issue Price
₹125
Per Share
GMP
NIL
Grey Market
Est. Listing
₹125
Expected Price
Min. Application
₹250,000
2 lots × 1000 shares
Nidan Laboratories & Healthcare Ltd. is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category.
Subscription opens 28 Oct 2021, closes 02 Nov 2021. Listing expected 10 Nov 2021. Apply via ASBA or UPI.
Nidan Laboratories & Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,000 | ₹125,000 |
| Retail (Max) | 13 | 13,000 | ₹1,625,000 |
| sNII (Min) | 14 | 14,000 | ₹1,750,000 |
| bNII (Min) | 68 | 68,000 | ₹8,500,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |